International Biotechnology Trust PLC Sage Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$40.65 - $59.54 $813,000 - $1.19 Million	20,000 New	20,000 $940,000
Q2 2021 Aug 11, 2021	SELL	$54.88 - $79.29 $1.18 Million - $1.7 Million	-21,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $1.52 Million - $2.08 Million	21,500 New	21,500 $1.61 Million
Q3 2020 Dec 01, 2020	SELL	$41.13 - $62.45 $1.55 Million - $2.35 Million	-37,600 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$26.15 - $77.24 $99,370 - $293,512	-3,800 Reduced 9.18%	37,600 $1.08 Million
Q4 2019 May 18, 2020	BUY	$60.18 - $154.77 $1.53 Million - $3.93 Million	25,400 Added 158.75%	41,400 $2.98 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $2.52 Million - $3.42 Million	-17,996 Reduced 52.94%	16,000 $2.25 Million
Q1 2019 May 14, 2019	BUY	$89.33 - $163.65 $1.61 Million - $2.95 Million	18,000 Added 112.53%	33,996 $5.41 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $684,611 - $837,931	-4,957 Reduced 23.66%	15,996 $1.73 Million
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $3.04 Million - $3.73 Million	-22,043 Reduced 51.27%	20,953 $809,000
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $3.86 Million - $4.83 Million	-27,500 Reduced 39.01%	42,996 $6.73 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $2.89 Million - $3.65 Million	19,000 Added 36.9%	70,496 $11.3 Million
Q4 2017 Mar 02, 2018	BUY	$60.72 - $167.34 $2.09 Million - $5.77 Million	34,500 Added 202.99%	51,496 $8.48 Million
Q4 2016 Mar 02, 2018	BUY	N/A	16,996	16,996 $867,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.